logo

For the Inventor, By the Inventor

Sandwich, United Kingdom

Charlotte Moira Norfor Allerton

This inventor holds 12 USPTO granted patents and 1 EPO patent. Top assignee: Pfizer Corporation. Active years: 2004-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charlotte Moira Norfor Allerton. Retrieved from https://idiyas.com/inventor/charlotte-moira-norfor-allerton

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 12

% Patents Active = 16.7


Average Co-Inventor Count = 4.1

ph-index = 5

Forward Citations = 131(Granted Patents)


Location History:

  • Kent, GB (2004 - 2005)
  • Sandwich, GB (2004 - 2011)

Company Filing History:

goldMedal12 out of 4,490 
 
Pfizer Corporation
 patents

Years Active: 2004-2011

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 7902188 - Morpholine dopamine agonists (2011-03-08),
2. 7576081 - Morpholine dopamine agonists (2009-08-18),
3. 7323462 - Morpholine dopamine agonists (2008-01-29),
4. 6958402 - 3-(imidazolyl)-2-alkoxypropanoic acids (2005-10-25),
5. 6949577 - Pharmaceuticals (2005-09-27),
6. 6919457 - 3-(imidazolyl)-2-aminopropanoic acids (2005-07-19),
7. 6809200 - Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-one compounds and intermediates thereof (2004-10-26),
8. 6794387 - Pharmaceutically active compounds (2004-09-21),
9. 6784185 - Pharmaceutically active compounds (2004-08-31),
10. 6759426 - 3-(Imidazolyl)-2-aminopropanoic acids (2004-07-06),
11. 6756373 - Pharmaceutically active compounds (2004-06-29),
12. 6713496 - 3-(imidazolyl)-2-alkoxypropanoic acids (2004-03-30),

Title: Innovations of Charlotte Moira Norfor Allerton

Introduction

Charlotte Moira Norfor Allerton is a prominent inventor based in Sandwich, GB. She has made significant contributions to the field of pharmaceuticals, holding a total of 12 patents. Her work primarily focuses on developing innovative compounds that have the potential to impact medical treatments.

Latest Patents

One of her latest patents includes the development of Morpholine dopamine agonists. This invention provides for compounds of formula (I), (Ia), and (Ib), which are designed to enhance dopamine receptor activity. These compounds are expected to play a crucial role in treating various neurological conditions.

Career Highlights

Charlotte is currently employed at Pfizer Corporation, a leading global pharmaceutical company. Her role involves extensive research and development, where she applies her expertise to create groundbreaking medical solutions. Her dedication to innovation has positioned her as a key player in her field.

Collaborations

Throughout her career, Charlotte has collaborated with notable colleagues, including Mark Edward Bunnage and John Steele. These partnerships have fostered a dynamic environment for creativity and advancement in pharmaceutical research.

Conclusion

Charlotte Moira Norfor Allerton exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions through her patents and collaborations continue to pave the way for future advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…